Peer Review History

Original SubmissionNovember 11, 2020
Decision Letter - Keqiang Wu, Editor

PONE-D-20-35417

Cloning and Functional characterization of seed-specific LEC1A promoter from peanut (Arachis hypogaea L.)

PLOS ONE

Dear Dr. Shan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 04 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Keqiang Wu, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for stating the following financial disclosure:

 "No"

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.
  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”
  3. If any authors received a salary from any of your funders, please state which authors and which funders.
  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3.Thank you for stating the following in your Competing Interests section: 

 "No"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall, this is a good experimental design. Here are some comments for the authors’ consideration -

1. The identified AhLEC1A is a homolog of Arabidopsis LEC1 – has this been supported by sequence alignment in this report or supported by appropriate references?

2. It is a logical alternative to use Arabidopsis for the promoter:GUS analysis, given that peanut was a difficult option to produce transgenic plants. However, the promoter;GUS analysis could be corroborated by tissue-specific RT-PCR to confirm the presence of the respective mRNA. Or, at least the expression of the similar Arabidopsis LEC1 promoter:GUS deletion constructs could be used as a control for a comparative expression analysis of the AhLEC1A promoter components. In absence of either of these supporting studies, the author needs to acknowledge the shortcomings of the promoter:GUS analysis alone in claiming spatial and temporal expression of AhLEC1A. (Ref #35 that claims to have shown expression of AhLEC1 is not available for non-Chinese readers and also it seems to support the Q7 GUS expression only)

Reviewer #2: In the current study, the authors have cloned a 2707 bp upstream sequence of the AhLEC1A gene from peanut and confirmed its transcription start site by 5' RACE. In addition, this study dissected the functions of the different regions of the AhLEC1A promoter under normal and dark/light conditions by using a promoter::GUS transgene approach in Arabidopsis. GUS staining showed that the 2300-bp AhLEC1A promoter (containing 82 bp of 5' UTR and 2228 bp promoter) was a seed-specific promoter and the expression pattern of this promoter may be controlled by several positive seed-specific regulatory elements and other negative regulatory elements. These findings will enhance the understanding of the regulatory mechanisms of the 2300-bp AhLEC1A promoter. I recommend it for publication in the journal after minor revisions.

Some points for the authors to consider in revision,

1. Research on the expression pattern of the LEC1 genes or functional analysis of the LEC1 promoters in different plants should be added in introduction. This will help readers understand the progress of the LEC1 promoter research.

2. The description of the transgenic lines is not detailed enough. The authors have not analyzed whether the transgenic Arabidopsis lines are single-copy or not. The expression and regulation of the transgene is correlated with the copy number of inserted transgenes.

3. The number of the transgenic lines in GUS staining analysis is a little small. Are the expression patterns of most of these transgenic lines (the major expression of the transformants) the same or similar?

4. The authors have cloned a 2707-bp upstream sequence of the AhLEC1A gene from peanut. However, they have not analyzed the activity of this longer promoter. The shorter 2300-bp AhLEC1A promoter (containing 82 bp of 5' UTR and 2228 bp promoter), not the longer 2707-bp promoter, was identified as the full length promoter of the AhLEC1A gene (Page 18, line 246, full-length AhLEC1A promoter (Q7)). Why?

5. The authors are suggested to add the positions of the deleted promoters in Figure 3, which would be more convenient to understand the paper.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear editor and reviewers,

I am very grateful to reviwer's valuable comments and suggestions. I have modified our manuscript, and the details revised are explained as follows.

Reviewer #1:

Q1:

The identified AhLEC1A is a homolog of Arabidopsis LEC1 – has this been supported by sequence alignment in this report or supported by appropriate references?

Answer: We identified AhLEC1A as a homolog of Arabidopsis AtLEC1 by clustering analysis and sequence alignment. LEC1 belongs to the B-subunit members of Nuclear Factor of the Y box (NF-Y) subfamily. We identified 19 NF-YB proteins from peanut genome, and aligned them with their homologous proteins from Arabidopsis and soybean. Their phylogenetic relationships were shown as following figure. It found that AhLEC1A and AhLEC1B were clustered together with Arabidopsis NF-YB9 (AtLEC1) and NF-YB6 (AtLEC1-like). On the other hand, the blast of sequence revealed that the identified AhLEC1A protein have higher sequence similarities with AtLEC1 in Arabidopsis. AhLEC1A shares respectively 57.64% and 85.71% identities of amino acid with AtLEC1 in ORF and B domain.

Q2: It is a logical alternative to use Arabidopsis for the promoter: GUS analysis, given that peanut was a difficult option to produce transgenic plants. However, the promoter;GUS analysis could be corroborated by tissue-specific RT-PCR to confirm the presence of the respective mRNA. Or, at least the expression of the similar Arabidopsis LEC1 promoter:GUS deletion constructs could be used as a control for a comparative expression analysis of the AhLEC1A promoter components. In absence of either of these supporting studies, the author needs to acknowledge the shortcomings of the promoter:GUS analysis alone in claiming spatial and temporal expression of AhLEC1A. (Ref #35 that claims to have shown expression of AhLEC1 is not available for non-Chinese readers and also it seems to support the Q7 GUS expression only)

Answer:

I agree with your comments and suggestions. The expressions of AhLEC1A in different tissues were analyzed by qRT-PCR, and showed to have the seed-specific pattern. We have added the relevant descriptions in the Materials and Methods(line 84-85, and line 118-123), and the Results section (line 218-220, S1 Fig.). And I have deleted the reference: “ Li AQ, Xia H, Wang XJ, Li CS, Zhao CZ, Bi YP. Cloning and expression analysis of peanut (Arachis hypogaea L.) LEC1. Acta Bot Boreal-OccidentSin. 2009; 29(9)(1730-1735. doi:10.1007/978-1-4020-9623-5_5 (In Chinese)”

Reviewer #2

Q1: Research on the expression pattern of the LEC1 genes or functional analysis of the LEC1 promoters in different plants should be added in introduction. This will help readers understand the progress of the LEC1 promoter research.

Answer:

I have supplied the relevant descriptions about the expression pattern of the LEC1 genes in different plants in line 50-51 and line 60-62, and cited three references (11, 21, 22) in the text.

11. Calvenzani V, Testoni B, Gusmaroli G, Lorenzo M, Gnesutta N, Petroni K, et al. Interactions and CCAAT-binding of Arabidopsis thaliana NF-Y subunits. PLoS One. 2012; 7(8): e42902. doi: 10.1371/journal.pone.0042902. PMID: 22912760

21. Baud S, Kelemen Z, Thévenin J , Boulard C, Blanchet S, To A, et al. Deciphering the molecular mechanisms underpinning the transcriptional control of gene expression by master transcriptional regulators in Arabidopsis seed. Plant Physiol. 2016;171(6): 1099–1112. doi;10.1104/pp.16.00034 PMID: 27208266

22. Jo L, Pelletier JM, Hsu SW, Baden R, Goldberg RB, Harada JJ. Combinatorial interactions of the LEC1 transcription factor specify diverse developmental programs during soybean seed development. Proc Natl Acad Sci U S A. 2020; 117 (2): 1223-1232.  doi:10.1073/pnas.1918441117 PMID: 31892538

Q2: The description of the transgenic lines is not detailed enough. The authors have not analyzed whether the transgenic Arabidopsis lines are single-copy or not.

Answer:

Many thanks for your comments. In fact, we analyzed the GUS expression driven by AhLEC1 promoters with different length using single-copy transgenic lines in current study. However, it was regretted to ignore the relevant descriptions. We have supplied the method of copy number analysis in transgenic lines in line 142-147 of the Materials and Methods section in revised manuscript.

Q3:

The number of the transgenic lines in GUS staining analysis is a little small. Are the expression patterns of most of these transgenic lines (the major expression of the transformants) the same or similar?

Answer:

Sorry, we didn’t express clearly about the number of the transgenic lines in GUS staining analysis in original manuscript. In our study, at least thirty plants of T2 generation lines in 5 transformed events of each GUS construct were used for GUS histochemical staining. The amounts of transgenic plants are enough to analyze the GUS expression. We have made it clear in revised manuscript at line 152-153. In addition, most of plants in each transformed construct have the similar expression pattern, and some lines with basically consistent expression patterns were selected to be their representatives of GUS expression patterns in different organs or developmental stages.

Q4:

The authors have cloned a 2707-bp upstream sequence of the AhLEC1A gene from peanut. However, they have not analyzed the activity of this longer promoter. The shorter 2300-bp AhLEC1A promoter (containing 82 bp of 5' UTR and 2228 bp promoter), not the longer 2707-bp promoter, was identified as the full length promoter of the AhLEC1A gene (Page 18, line 246, full-length AhLEC1A promoter (Q7)). Why?

Answer:

We have cloned a 2707bp upstream sequence from the ATG initiation codon site of AhLEC1A. The bioinformatics analysis revealed that most of elements, including some elements involved in embyogenesis and seed storage compounds accumulation, located in the region of -2228 ~ +82 nt (2300bp), and fewer elements distributed in -2229 ~ -2707 nt region. It suggests that the 2300bp promoter could mainly be responsible for regulating the spatiotemporal expression of AhLEC1A. Therefore, we analyzed the activity of the 2300-bp promoter, which was the longest one among all promoters analyzed in our study, instead of full-length 2707-bp promoter. Because it is not suitable for calling 2300-bp promoter as full length, we have corrected it in the text.

Q5:

The authors are suggested to add the positions of the deleted promoters in Figure 3, which would be more convenient to understand the paper.

Answer:

According to your suggestion, we have marked the positions of primers P1-P8 using the shaded sequences in Figure 3. The P2-P8 as the forward primers (marked with ‘→’) together with reverse primer P1 (marked with ‘←’) respectively were used to amplify seven promoter segments Q1-Q7. Therefore, the deleted fragments at 5'-terminus of these promoters can be convenient to distinguish in Figure 3, and the lengths of the promoters have been clearly displayed in Figure 4.

Attachments
Attachment
Submitted filename: Response to Reviewers-final.docx
Decision Letter - Keqiang Wu, Editor

Cloning and Functional characterization of seed-specific LEC1A promoter from peanut (Arachis hypogaea L.)

PONE-D-20-35417R1

Dear Dr. Shan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Keqiang Wu, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors: thanks for addressing the comments/ feedback. The phylogenetic analysis and the qRT-PCR figure could be a part of the main manuscript. Good work.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Keqiang Wu, Editor

PONE-D-20-35417R1

Cloning and Functional characterization of seed-specific LEC1A promoter from peanut (Arachis hypogaea L.)

Dear Dr. Shan:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Keqiang Wu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .